US Patent 7173022 Bicyclic heterocycles as HIV integrase inhibitors

Patent 7173022 was granted and assigned to Bristol-Myers Squibb on February, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7173022

Date of Patent

February 6, 2007

Patent Application Number

11138773

Date Filed

May 26, 2005

Patent Primary Examiner

‌

Mark Berch

Patent abstract

The invention encompasses a series cyclic bicyclic heterocyclic compounds of Formula I which are inhibitors of HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV